COPIKTRA vs ONCASPAR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. COPIKTRA and ONCASPAR are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	COPIKTRA	ONCASPAR
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	DUVELISIB	PEGASPARGASE
Manufacturer	Secura	Sigma Tau
Dosage forms	Capsule	Injectable
Drug class	—	—
Boxed warning	Boxed warning	None
Treats	B-Cell Chronic Lymphocytic Leukemia	Blast Crisis, Non-Hodgkin Lymphoma, B-Cell Chronic Lymphocytic Leukemia

copiktra oncaspar

Rating

New

Pharmacy pays

—

Type

Active ingredient

DUVELISIB

PEGASPARGASE

Manufacturer

Secura

Sigma Tau

Dosage forms

Capsule

Injectable

Drug class

—

Boxed warning

None

Treats

B-Cell Chronic Lymphocytic Leukemia

Blast Crisis, Non-Hodgkin Lymphoma, B-Cell Chronic Lymphocytic Leukemia

Frequently asked questions

What is the difference between Copiktra and Oncaspar?

Copiktra contains Duvelisib, while Oncaspar contains Pegaspargase — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.